β-Lactamase inhibitors: a review of the patent literature (2010 – 2013)

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.11, 2013-11, pp. : 1469-1481

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

β-Lactamase inhibitors: a survey of the patent literature 2000 – 2004

By Phillips Oludotun A

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 3, 2006-03 ,pp. : 319-331

Informa Healthcare

Access to resources Recommend Favorite

Spleen tyrosine kinase inhibitors: a review of the patent literature 2010 – 2013

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 5, 2014-05 ,pp. : 573-595

Informa Healthcare

Access to resources Recommend Favorite

β-Lactamase Inhibitors: An Update

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 13, 2013-11 ,pp. : 1846-1861

Bentham Science Publishers

Access to resources Recommend Favorite

New β-lactam antibiotics and β-lactamase inhibitors

By Bush Karen Macielag Mark J

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 10, 2010-10 ,pp. : 1277-1293

Informa Healthcare

Access to resources Recommend Favorite

Cyclooxygenase-2 inhibitors: a literature and patent review (2009 – 2010)

By Jawabrah Al-Hourani Baker Sharma Sai Kiran Suresh Mavanur Wuest Frank

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 9, 2011-09 ,pp. : 1339-1432

Informa Healthcare

Access to resources Recommend Favorite